Soy protein isolate reduces the oxidizability of LDL and the generation of oxidized LDL autoantibodies in rabbits with diet-induced atherosclerosis.
The incidence of atherosclerosis can be modified by diet, and plant-derived proteins have a beneficial effect, but the underlying mechanisms remain unclear. It has been suggested that oxidized LDL (oxLDL) and autoantibodies against oxLDL are important in the development of atherosclerosis. We analyzed these factors in rabbits fed a nonpurified diet supplemented with high cholesterol (10.0 g/kg) containing either 270.0 g/kg casein (CAS, n = 10) or 270.0 g/kg soy protein isolate (SPI, n = 10) for 2 mo. Plasma and purified serum LDL from rabbits were analyzed at d 0, 15, 30, 45 and 60 of treatment, and the size of atherosclerotic lesions was evaluated at d 60 of treatment. CAS-fed rabbits had significantly higher plasma cholesterol at d 15-45 and LDL cholesterol levels at d 15 and 30. Levels of trilinolein and phosphatidylcholine hydroperoxides were higher in the LDL fraction of rabbits fed CAS than in those fed SPI. Also, CAS-fed rabbits had higher levels of highly oxidized LDL [monoclonal antibody (mAb) 24-reactive oxLDL] in plasma at d 60, whereas SPI-fed rabbits had higher levels of minimally oxidized LDL (mAb 28-reactive oxLDL) at d 45. These results were consistent with the earlier formation of anti-oxLDL antibodies and the presence of a larger area of atherosclerotic lesion in rabbits fed the CAS diet. These data indicate the importance of both the type of dietary protein used in the induction of atherosclerosis and the relevance of immunologic mechanisms in addition to biochemical and physiologic factors in the pathogenesis of atherosclerosis.
Damasceno
N R
NR
Departamentos de Alimentos e Nutrição Experimental e. Análises Clínicas e Toxicológicas, Faculdade de Ciências Farmacêuticas, Sao Paulo, Brazil.
Goto
H
H
Rodrigues
F M
FM
Dias
C T
CT
Okawabata
F S
FS
Abdalla
D S
DS
Gidlund
M
M
D000704:Analysis of Variance; D000818:Animals; D001161:Arteriosclerosis / Q000139:chemically induced* / Q000378:metabolism / Q000517:prevention & control; D001323:Autoantibodies / Q000096:biosynthesis; D002364:Caseins / Q000008:administration & dosage / Q000494:pharmacology*; D002791:Cholesterol, Dietary / Q000008:administration & dosage / Q000009:adverse effects*; D008078:Cholesterol, LDL / Q000097:blood; D004032:Diet; D004797:Enzyme-Linked Immunosorbent Assay; D008074:Lipoproteins / Q000378:metabolism*; D008297:Male; D010084:Oxidation-Reduction / Q000187:drug effects; D011817:Rabbits; D030262:Soybean Proteins / Q000008:administration & dosage / Q000627:therapeutic use*
D001323:Autoantibodies; D002364:Caseins; D002791:Cholesterol, Dietary; D008078:Cholesterol, LDL; D008074:Lipoproteins; D030262:Soybean Proteins